From: The aquaporin4-IgG status and how it affects the clinical features and treatment response in NMOSD patients in Egypt
1st Drug
N = 41
(F/T)
2nd Drug
N = 15
3rd Drug
N = 6
Azathioprine (n)
10/22
4/8
2/2
Rituximab(n)
3/7
1/2
1/3
Cyclophosphamide(n)
1/1
Mitoxantrone (n)
3/3
0
Mycophenolate (n)